Multiple Endocrine Neoplasia Type 1, Type 2A, and Type 2B.
Greenberg LA.
Prim Care. 2024 Sep;51(3):483-494. doi: 10.1016/j.pop.2024.03.006. Epub 2024 May 23.
Multiple endocrine neoplasia type 2a (MEN2a): a call for psycho-social research.
Giarelli E.
Psychooncology. 2002 Jan-Feb;11(1):59-73. doi: 10.1002/pon.546.
Multiple endocrine neoplasia.
White ML, Doherty GM.
Surg Oncol Clin N Am. 2008 Apr;17(2):439-59, x. doi: 10.1016/j.soc.2007.12.002.
Multiple endocrine neoplasia type 2A syndrome presenting with corneal nerve thickening.
Petrie I, Knox Cartwright N, Roberts H, Kyrodimou E, Moudiotis C, Owens M, Cleaver R, Smith J, Vaidya B.
QJM. 2024 Mar 27;117(3):226-228. doi: 10.1093/qjmed/hcad259.
Non-mammalian models of multiple endocrine neoplasia type 2.
Das TK, Cagan RL.
Endocr Relat Cancer. 2018 Feb;25(2):T91-T104. doi: 10.1530/ERC-17-0411.
Update on multiple endocrine neoplasia Type 1 and 2.
Al-Salameh A, Baudry C, Cohen R.
Presse Med. 2018 Sep;47(9):722-731. doi: 10.1016/j.lpm.2018.03.005. Epub 2018 Jun 13.
[Multiple endocrine neoplasia type 2A in a family].
Hircsu I, Gazdag A, Bodor M, Berta E, Andrási M, Kanyári Z, Győry F, Barna S, Bhattoa HP, Nagy B, Nagy VE, Erdei A.
Orv Hetil. 2020 Jan;161(2):75-79. doi: 10.1556/650.2020.31595.
Evolution of surgical treatment of primary hyperparathyroidism in patients with multiple endocrine neoplasia type 2A.
Scholten A, Schreinemakers JM, Pieterman CR, Valk GD, Vriens MR, Borel Rinkes IH.
Endocr Pract. 2011 Jan-Feb;17(1):7-15. doi: 10.4158/EP10050.OR.
Pheochromocytomas in Multiple Endocrine Neoplasia Type 2.
Tsang VH, Tacon LJ, Learoyd DL, Robinson BG.
Recent Results Cancer Res. 2015;204:157-78. doi: 10.1007/978-3-319-22542-5_7.
The molecular genetics of multiple endocrine neoplasia type 2A and related syndromes.
Moley JF.
Annu Rev Med. 1997;48:409-20. doi: 10.1146/annurev.med.48.1.409.
